APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Prevent Meningitis Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Prevent Meningitis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174028390330 December 2025196 pages

Choose your research edition.

Industry ResearchPrevent Meningitis Vaccine Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Prevent Meningitis Vaccine Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Prevent Meningitis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prevent Meningitis Vaccine Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Prevent Meningitis Vaccine Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Prevent Meningitis Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Prevent Meningitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Prevent Meningitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prevent Meningitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Prevent Meningitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Prevent Meningitis Vaccine include GSK, China National Biotec Group, Zhejiang Tianyuan, Sanofi Pasteur, Novartis, Merck, Tianjin CanSino Biotechnology, Pfizer and Hualan Bio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Prevent Meningitis Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Prevent Meningitis Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Prevent Meningitis Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Prevent Meningitis Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Prevent Meningitis Vaccine Segment by Company

GSK

China National Biotec Group

Zhejiang Tianyuan

Sanofi Pasteur

Novartis

Merck

Tianjin CanSino Biotechnology

Pfizer

Hualan Bio

Beijing Tiantan Biological

Baxter International

Zhifei

Wyeth Pharmaceuticals, Inc

Walvax

Serum Institute of India

JN International Medical Corporation

CSL Behring

Bio-Med

Prevent Meningitis Vaccine Segment by Type

Meningococcal AC Vaccine

Meningococcal A Vaccine

Meningococcal B Vaccine (MenB)

Meningococcal Conjugate Vaccine (MenaCWY)

Prevent Meningitis Vaccine Segment by Application

Baby

Teenager

Child

Others

Prevent Meningitis Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prevent Meningitis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prevent Meningitis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prevent Meningitis Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Prevent Meningitis Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Prevent Meningitis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Prevent Meningitis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Prevent Meningitis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Prevent Meningitis Vaccine Industry Trends Table 2. Prevent Meningitis Vaccine Industry Drivers Table 3. Prevent Meningitis Vaccine Industry Opportunities and Challenges Table 4. Prevent Meningitis Vaccine Industry Restraints Table 5. Global Prevent Meningitis Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Prevent Meningitis Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Prevent Meningitis Vaccine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Prevent Meningitis Vaccine Sales Market Share by Manufacturers Table 9. Global Prevent Meningitis Vaccine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Prevent Meningitis Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Prevent Meningitis Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Prevent Meningitis Vaccine Manufacturers, Product Type & Application Table 13. Global Prevent Meningitis Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Prevent Meningitis Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Meningococcal AC Vaccine Table 17. Major Manufacturers of Meningococcal A Vaccine Table 18. Major Manufacturers of Meningococcal B Vaccine (MenB) Table 19. Major Manufacturers of Meningococcal Conjugate Vaccine (MenaCWY) Table 20. Global Prevent Meningitis Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Prevent Meningitis Vaccine Sales by Type (2021-2026) & (K Units) Table 22. Global Prevent Meningitis Vaccine Sales by Type (2027-2032) & (K Units) Table 23. Global Prevent Meningitis Vaccine Sales Market Share by Type (2021-2026) Table 24. Global Prevent Meningitis Vaccine Sales Market Share by Type (2027-2032) Table 25. Global Prevent Meningitis Vaccine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Prevent Meningitis Vaccine Revenue by Type (2021-2026) & (K Units) Table 27. Global Prevent Meningitis Vaccine Revenue by Type (2027-2032) & (K Units) Table 28. Global Prevent Meningitis Vaccine Revenue Market Share by Type (2021-2026) Table 29. Global Prevent Meningitis Vaccine Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Baby Table 31. Major Manufacturers of Teenager Table 32. Major Manufacturers of Child Table 33. Major Manufacturers of Others Table 34. Global Prevent Meningitis Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Prevent Meningitis Vaccine Sales by Application (2021-2026) & (K Units) Table 36. Global Prevent Meningitis Vaccine Sales by Application (2027-2032) & (K Units) Table 37. Global Prevent Meningitis Vaccine Sales Market Share by Application (2021-2026) Table 38. Global Prevent Meningitis Vaccine Sales Market Share by Application (2027-2032) Table 39. Global Prevent Meningitis Vaccine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Prevent Meningitis Vaccine Revenue by Application (2021-2026) & (K Units) Table 41. Global Prevent Meningitis Vaccine Revenue by Application (2027-2032) & (K Units) Table 42. Global Prevent Meningitis Vaccine Revenue Market Share by Application (2021-2026) Table 43. Global Prevent Meningitis Vaccine Revenue Market Share by Application (2027-2032) Table 44. Global Prevent Meningitis Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Prevent Meningitis Vaccine Sales by Region (2021-2026) & (K Units) Table 46. Global Prevent Meningitis Vaccine Sales Market Share by Region (2021-2026) Table 47. Global Prevent Meningitis Vaccine Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Prevent Meningitis Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Prevent Meningitis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Prevent Meningitis Vaccine Sales by Country (2021-2026) & (K Units) Table 51. North America Prevent Meningitis Vaccine Sales by Country (2027-2032) & (K Units) Table 52. Europe Prevent Meningitis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Prevent Meningitis Vaccine Sales by Country (2021-2026) & (K Units) Table 54. Europe Prevent Meningitis Vaccine Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Prevent Meningitis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Prevent Meningitis Vaccine Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Prevent Meningitis Vaccine Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Prevent Meningitis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Prevent Meningitis Vaccine Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Prevent Meningitis Vaccine Sales by Country (2027-2032) & (K Units) Table 61. Global Prevent Meningitis Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Prevent Meningitis Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Prevent Meningitis Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Prevent Meningitis Vaccine Revenue Market Share by Region (2021-2026) Table 65. Global Prevent Meningitis Vaccine Revenue Market Share by Region (2027-2032) Table 66. GSK Company Information Table 67. GSK Business Overview Table 68. GSK Prevent Meningitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. GSK Prevent Meningitis Vaccine Product Portfolio Table 70. GSK Recent Development Table 71. China National Biotec Group Company Information Table 72. China National Biotec Group Business Overview Table 73. China National Biotec Group Prevent Meningitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. China National Biotec Group Prevent Meningitis Vaccine Product Portfolio Table 75. China National Biotec Group Recent Development Table 76. Zhejiang Tianyuan Company Information Table 77. Zhejiang Tianyuan Business Overview Table 78. Zhejiang Tianyuan Prevent Meningitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Zhejiang Tianyuan Prevent Meningitis Vaccine Product Portfolio Table 80. Zhejiang Tianyuan Recent Development Table 81. Sanofi Pasteur Company Information Table 82. Sanofi Pasteur Business Overview Table 83. Sanofi Pasteur Prevent Meningitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Sanofi Pasteur Prevent Meningitis Vaccine Product Portfolio Table 85. Sanofi Pasteur Recent Development Table 86. Novartis Company Information Table 87. Novartis Business Overview Table 88. Novartis Prevent Meningitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Novartis Prevent Meningitis Vaccine Product Portfolio Table 90. Novartis Recent Development Table 91. Merck Company Information Table 92. Merck Business Overview Table 93. Merck Prevent Meningitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Merck Prevent Meningitis Vaccine Product Portfolio Table 95. Merck Recent Development Table 96. Tianjin CanSino Biotechnology Company Information Table 97. Tianjin CanSino Biotechnology Business Overview Table 98. Tianjin CanSino Biotechnology Prevent Meningitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Tianjin CanSino Biotechnology Prevent Meningitis Vaccine Product Portfolio Table 100. Tianjin CanSino Biotechnology Recent Development Table 101. Pfizer Company Information Table 102. Pfizer Business Overview Table 103. Pfizer Prevent Meningitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Pfizer Prevent Meningitis Vaccine Product Portfolio Table 105. Pfizer Recent Development Table 106. Hualan Bio Company Information Table 107. Hualan Bio Business Overview Table 108. Hualan Bio Prevent Meningitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Hualan Bio Prevent Meningitis Vaccine Product Portfolio Table 110. Hualan Bio Recent Development Table 111. Beijing Tiantan Biological Company Information Table 112. Beijing Tiantan Biological Business Overview Table 113. Beijing Tiantan Biological Prevent Meningitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Beijing Tiantan Biological Prevent Meningitis Vaccine Product Portfolio Table 115. Beijing Tiantan Biological Recent Development Table 116. Baxter International Company Information Table 117. Baxter International Business Overview Table 118. Baxter International Prevent Meningitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Baxter International Prevent Meningitis Vaccine Product Portfolio Table 120. Baxter International Recent Development Table 121. Zhifei Company Information Table 122. Zhifei Business Overview Table 123. Zhifei Prevent Meningitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Zhifei Prevent Meningitis Vaccine Product Portfolio Table 125. Zhifei Recent Development Table 126. Wyeth Pharmaceuticals, Inc Company Information Table 127. Wyeth Pharmaceuticals, Inc Business Overview Table 128. Wyeth Pharmaceuticals, Inc Prevent Meningitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Wyeth Pharmaceuticals, Inc Prevent Meningitis Vaccine Product Portfolio Table 130. Wyeth Pharmaceuticals, Inc Recent Development Table 131. Walvax Company Information Table 132. Walvax Business Overview Table 133. Walvax Prevent Meningitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Walvax Prevent Meningitis Vaccine Product Portfolio Table 135. Walvax Recent Development Table 136. Serum Institute of India Company Information Table 137. Serum Institute of India Business Overview Table 138. Serum Institute of India Prevent Meningitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. Serum Institute of India Prevent Meningitis Vaccine Product Portfolio Table 140. Serum Institute of India Recent Development Table 141. JN International Medical Corporation Company Information Table 142. JN International Medical Corporation Business Overview Table 143. JN International Medical Corporation Prevent Meningitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. JN International Medical Corporation Prevent Meningitis Vaccine Product Portfolio Table 145. JN International Medical Corporation Recent Development Table 146. CSL Behring Company Information Table 147. CSL Behring Business Overview Table 148. CSL Behring Prevent Meningitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 149. CSL Behring Prevent Meningitis Vaccine Product Portfolio Table 150. CSL Behring Recent Development Table 151. Bio-Med Company Information Table 152. Bio-Med Business Overview Table 153. Bio-Med Prevent Meningitis Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 154. Bio-Med Prevent Meningitis Vaccine Product Portfolio Table 155. Bio-Med Recent Development Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Prevent Meningitis Vaccine Distributors List Table 159. Prevent Meningitis Vaccine Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Prevent Meningitis Vaccine Product Image Figure 2. Global Prevent Meningitis Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prevent Meningitis Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Prevent Meningitis Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Prevent Meningitis Vaccine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Prevent Meningitis Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Meningococcal AC Vaccine Image Figure 9. Meningococcal A Vaccine Image Figure 10. Meningococcal B Vaccine (MenB) Image Figure 11. Meningococcal Conjugate Vaccine (MenaCWY) Image Figure 12. Global Prevent Meningitis Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Prevent Meningitis Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Prevent Meningitis Vaccine Sales Market Share by Type (2021-2032) Figure 15. Global Prevent Meningitis Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Prevent Meningitis Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Prevent Meningitis Vaccine Revenue Market Share by Type (2021-2032) Figure 18. Baby Image Figure 19. Teenager Image Figure 20. Child Image Figure 21. Others Image Figure 22. Global Prevent Meningitis Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Prevent Meningitis Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Prevent Meningitis Vaccine Sales Market Share by Application (2021-2032) Figure 25. Global Prevent Meningitis Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Prevent Meningitis Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Prevent Meningitis Vaccine Revenue Market Share by Application (2021-2032) Figure 28. North America Prevent Meningitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Prevent Meningitis Vaccine Sales Market Share by Country (2021-2032) Figure 30. U.S. Prevent Meningitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Prevent Meningitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Prevent Meningitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Prevent Meningitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Prevent Meningitis Vaccine Sales Market Share by Country (2021-2032) Figure 35. Germany Prevent Meningitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Prevent Meningitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Prevent Meningitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Prevent Meningitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Prevent Meningitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Prevent Meningitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Prevent Meningitis Vaccine Sales Market Share by Country (2021-2032) Figure 42. China Prevent Meningitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Prevent Meningitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Prevent Meningitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Prevent Meningitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Prevent Meningitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Prevent Meningitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Prevent Meningitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Prevent Meningitis Vaccine Sales Market Share by Country (2021-2032) Figure 50. Brazil Prevent Meningitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Prevent Meningitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Prevent Meningitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Prevent Meningitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Prevent Meningitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Prevent Meningitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Prevent Meningitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Prevent Meningitis Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Prevent Meningitis Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Prevent Meningitis Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Prevent Meningitis Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. North America Prevent Meningitis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Prevent Meningitis Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. Europe Prevent Meningitis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Prevent Meningitis Vaccine Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Prevent Meningitis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Prevent Meningitis Vaccine Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Prevent Meningitis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Prevent Meningitis Vaccine Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Prevent Meningitis Vaccine Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Meningococcal AC Vaccine
  • Meningococcal A Vaccine
  • Meningococcal B Vaccine (MenB)
  • Meningococcal Conjugate Vaccine (MenaCWY)
Applications
  • Baby
  • Teenager
  • Child
  • Others
Companies covered
  • GSK
  • China National Biotec Group
  • Zhejiang Tianyuan
  • Sanofi Pasteur
  • Novartis
  • Merck
  • Tianjin CanSino Biotechnology
  • Pfizer
  • Hualan Bio
  • Beijing Tiantan Biological
  • Baxter International
  • Zhifei
  • Wyeth Pharmaceuticals, Inc
  • Walvax
  • Serum Institute of India
  • JN International Medical Corporation
  • CSL Behring
  • Bio-Med

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Prevent Meningitis Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Prevent Meningitis Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Prevent Meningitis Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Prevent Meningitis Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Prevent Meningitis Vaccine Market Dynamics
  1. 2.1 Prevent Meningitis Vaccine Industry Trends
  2. 2.2 Prevent Meningitis Vaccine Industry Drivers
  3. 2.3 Prevent Meningitis Vaccine Industry Opportunities and Challenges
  4. 2.4 Prevent Meningitis Vaccine Industry Restraints
3 Prevent Meningitis Vaccine Market by Manufacturers
  1. 3.1 Global Prevent Meningitis Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Prevent Meningitis Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Prevent Meningitis Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Prevent Meningitis Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Prevent Meningitis Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Prevent Meningitis Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Prevent Meningitis Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Prevent Meningitis Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Prevent Meningitis Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Prevent Meningitis Vaccine Tier 1, Tier 2, and Tier 3
4 Prevent Meningitis Vaccine Market by Type
  1. 4.1 Prevent Meningitis Vaccine Type Introduction
  2. 4.1.1 Meningococcal AC Vaccine
  3. 4.1.2 Meningococcal A Vaccine
  4. 4.1.3 Meningococcal B Vaccine (MenB)
  5. 4.1.4 Meningococcal Conjugate Vaccine (MenaCWY)
  6. 4.2 Global Prevent Meningitis Vaccine Sales by Type
  7. 4.2.1 Global Prevent Meningitis Vaccine Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Prevent Meningitis Vaccine Sales by Type (2021-2032)
  9. 4.2.3 Global Prevent Meningitis Vaccine Sales Market Share by Type (2021-2032)
  10. 4.3 Global Prevent Meningitis Vaccine Revenue by Type
  11. 4.3.1 Global Prevent Meningitis Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Prevent Meningitis Vaccine Revenue by Type (2021-2032)
  13. 4.3.3 Global Prevent Meningitis Vaccine Revenue Market Share by Type (2021-2032)
5 Prevent Meningitis Vaccine Market by Application
  1. 5.1 Prevent Meningitis Vaccine Application Introduction
  2. 5.1.1 Baby
  3. 5.1.2 Teenager
  4. 5.1.3 Child
  5. 5.1.4 Others
  6. 5.2 Global Prevent Meningitis Vaccine Sales by Application
  7. 5.2.1 Global Prevent Meningitis Vaccine Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Prevent Meningitis Vaccine Sales by Application (2021-2032)
  9. 5.2.3 Global Prevent Meningitis Vaccine Sales Market Share by Application (2021-2032)
  10. 5.3 Global Prevent Meningitis Vaccine Revenue by Application
  11. 5.3.1 Global Prevent Meningitis Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Prevent Meningitis Vaccine Revenue by Application (2021-2032)
  13. 5.3.3 Global Prevent Meningitis Vaccine Revenue Market Share by Application (2021-2032)
6 Global Prevent Meningitis Vaccine Sales by Region
  1. 6.1 Global Prevent Meningitis Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Prevent Meningitis Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Prevent Meningitis Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Prevent Meningitis Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Prevent Meningitis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Prevent Meningitis Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Prevent Meningitis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Prevent Meningitis Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Prevent Meningitis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Prevent Meningitis Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Prevent Meningitis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Prevent Meningitis Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Prevent Meningitis Vaccine Revenue by Region
  1. 7.1 Global Prevent Meningitis Vaccine Revenue by Region
  2. 7.1.1 Global Prevent Meningitis Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Prevent Meningitis Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Prevent Meningitis Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Prevent Meningitis Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Prevent Meningitis Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Prevent Meningitis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Prevent Meningitis Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Prevent Meningitis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Prevent Meningitis Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Prevent Meningitis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Prevent Meningitis Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Prevent Meningitis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 GSK Prevent Meningitis Vaccine Product Portfolio
  6. 8.1.5 GSK Recent Developments
  7. 8.2 China National Biotec Group
  8. 8.2.1 China National Biotec Group Company Information
  9. 8.2.2 China National Biotec Group Business Overview
  10. 8.2.3 China National Biotec Group Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 China National Biotec Group Prevent Meningitis Vaccine Product Portfolio
  12. 8.2.5 China National Biotec Group Recent Developments
  13. 8.3 Zhejiang Tianyuan
  14. 8.3.1 Zhejiang Tianyuan Company Information
  15. 8.3.2 Zhejiang Tianyuan Business Overview
  16. 8.3.3 Zhejiang Tianyuan Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Zhejiang Tianyuan Prevent Meningitis Vaccine Product Portfolio
  18. 8.3.5 Zhejiang Tianyuan Recent Developments
  19. 8.4 Sanofi Pasteur
  20. 8.4.1 Sanofi Pasteur Company Information
  21. 8.4.2 Sanofi Pasteur Business Overview
  22. 8.4.3 Sanofi Pasteur Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sanofi Pasteur Prevent Meningitis Vaccine Product Portfolio
  24. 8.4.5 Sanofi Pasteur Recent Developments
  25. 8.5 Novartis
  26. 8.5.1 Novartis Company Information
  27. 8.5.2 Novartis Business Overview
  28. 8.5.3 Novartis Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Novartis Prevent Meningitis Vaccine Product Portfolio
  30. 8.5.5 Novartis Recent Developments
  31. 8.6 Merck
  32. 8.6.1 Merck Company Information
  33. 8.6.2 Merck Business Overview
  34. 8.6.3 Merck Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Merck Prevent Meningitis Vaccine Product Portfolio
  36. 8.6.5 Merck Recent Developments
  37. 8.7 Tianjin CanSino Biotechnology
  38. 8.7.1 Tianjin CanSino Biotechnology Company Information
  39. 8.7.2 Tianjin CanSino Biotechnology Business Overview
  40. 8.7.3 Tianjin CanSino Biotechnology Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Tianjin CanSino Biotechnology Prevent Meningitis Vaccine Product Portfolio
  42. 8.7.5 Tianjin CanSino Biotechnology Recent Developments
  43. 8.8 Pfizer
  44. 8.8.1 Pfizer Company Information
  45. 8.8.2 Pfizer Business Overview
  46. 8.8.3 Pfizer Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Pfizer Prevent Meningitis Vaccine Product Portfolio
  48. 8.8.5 Pfizer Recent Developments
  49. 8.9 Hualan Bio
  50. 8.9.1 Hualan Bio Company Information
  51. 8.9.2 Hualan Bio Business Overview
  52. 8.9.3 Hualan Bio Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Hualan Bio Prevent Meningitis Vaccine Product Portfolio
  54. 8.9.5 Hualan Bio Recent Developments
  55. 8.10 Beijing Tiantan Biological
  56. 8.10.1 Beijing Tiantan Biological Company Information
  57. 8.10.2 Beijing Tiantan Biological Business Overview
  58. 8.10.3 Beijing Tiantan Biological Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Beijing Tiantan Biological Prevent Meningitis Vaccine Product Portfolio
  60. 8.10.5 Beijing Tiantan Biological Recent Developments
  61. 8.11 Baxter International
  62. 8.11.1 Baxter International Company Information
  63. 8.11.2 Baxter International Business Overview
  64. 8.11.3 Baxter International Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Baxter International Prevent Meningitis Vaccine Product Portfolio
  66. 8.11.5 Baxter International Recent Developments
  67. 8.12 Zhifei
  68. 8.12.1 Zhifei Company Information
  69. 8.12.2 Zhifei Business Overview
  70. 8.12.3 Zhifei Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Zhifei Prevent Meningitis Vaccine Product Portfolio
  72. 8.12.5 Zhifei Recent Developments
  73. 8.13 Wyeth Pharmaceuticals, Inc
  74. 8.13.1 Wyeth Pharmaceuticals, Inc Company Information
  75. 8.13.2 Wyeth Pharmaceuticals, Inc Business Overview
  76. 8.13.3 Wyeth Pharmaceuticals, Inc Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Wyeth Pharmaceuticals, Inc Prevent Meningitis Vaccine Product Portfolio
  78. 8.13.5 Wyeth Pharmaceuticals, Inc Recent Developments
  79. 8.14 Walvax
  80. 8.14.1 Walvax Company Information
  81. 8.14.2 Walvax Business Overview
  82. 8.14.3 Walvax Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Walvax Prevent Meningitis Vaccine Product Portfolio
  84. 8.14.5 Walvax Recent Developments
  85. 8.15 Serum Institute of India
  86. 8.15.1 Serum Institute of India Company Information
  87. 8.15.2 Serum Institute of India Business Overview
  88. 8.15.3 Serum Institute of India Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Serum Institute of India Prevent Meningitis Vaccine Product Portfolio
  90. 8.15.5 Serum Institute of India Recent Developments
  91. 8.16 JN International Medical Corporation
  92. 8.16.1 JN International Medical Corporation Company Information
  93. 8.16.2 JN International Medical Corporation Business Overview
  94. 8.16.3 JN International Medical Corporation Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 JN International Medical Corporation Prevent Meningitis Vaccine Product Portfolio
  96. 8.16.5 JN International Medical Corporation Recent Developments
  97. 8.17 CSL Behring
  98. 8.17.1 CSL Behring Company Information
  99. 8.17.2 CSL Behring Business Overview
  100. 8.17.3 CSL Behring Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 CSL Behring Prevent Meningitis Vaccine Product Portfolio
  102. 8.17.5 CSL Behring Recent Developments
  103. 8.18 Bio-Med
  104. 8.18.1 Bio-Med Company Information
  105. 8.18.2 Bio-Med Business Overview
  106. 8.18.3 Bio-Med Prevent Meningitis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Bio-Med Prevent Meningitis Vaccine Product Portfolio
  108. 8.18.5 Bio-Med Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Prevent Meningitis Vaccine Value Chain Analysis
  2. 9.1.1 Prevent Meningitis Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Prevent Meningitis Vaccine Production Mode & Process
  6. 9.2 Prevent Meningitis Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Prevent Meningitis Vaccine Distributors
  9. 9.2.3 Prevent Meningitis Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst